Biogen Idec prepares for multiple launches in coming years The Pharma Letter ... which will both have data readouts this year. o Delivering the data readout from the first Phase III trial of dexpramipexole in ALS by year-end. o Continuing to advance the daclizumab Phase III program in MS. o Building world-class scientific teams ... |
